Gilead Sciences (GILD) net assets (shareholders' equity)

Net assets · fiscal 2025
$22.70B

Gilead Sciences (GILD) had net assets of $22.70B at the end of fiscal 2025 (December 31, 2025). That is 17.4% higher than the $19.33B of fiscal 2024. Figures as of 18 Nov 2026, 20:50 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Net assets, fiscal 2025
$22.70B
Change on fiscal 2024
+17.4%
Growth, 5 years
+4.5% a year
Growth, 10 years
+2.0% a year
Highest on record
$22.83Bfiscal 2023
Lowest on record
$3.75Bfiscal 2007
Fiscal years on record
192007–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Gilead Sciences net assets (shareholders' equity), in more detail

Over the five fiscal years to 2025 net assets grew at a compound 4.5% a year; over ten years the rate was 2.0% a year. Across the 19 fiscal years on record (2007–2025), the highest was $22.83B in fiscal 2023 and the lowest $3.75B in fiscal 2007.

History · 19 fiscal years

Net assets by fiscal year

Gilead Sciences net assets (shareholders' equity), year by year

Gilead Sciences (GILD) net assets (shareholders' equity) by fiscal year
Fiscal yearNet assetsChangeYear ended
2025$22.70B 17.4% up
2024$19.33B 15.3% down
2023$22.83B 7.5% up
2022$21.24B 0.8% up
2021$21.07B 15.8% up
2020$18.20B 19.2% down
2019$22.53B 5.3% up
2018$21.39B 4.6% up
2017$20.44B 8.2% up
2016$18.89B 1.9% up
2015$18.53B 20.1% up
2014$15.43B 35.7% up
2013$11.37B 22.2% up
2012$9.30B 38.0% up
2011$6.74B 14.9% up
2010$5.86B 7.9% down
2009$6.37B 49.0% up
2008$4.27B 13.9% up
2007$3.75B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value.

How to read it

Large buybacks and write-offs shrink it without the business getting worse, so a falling or negative figure needs the reason before a verdict.

Net assets at health care companies of similar size

Net assets of Gilead Sciences and comparable companies
CompanyNet assetsFiscal year
Thermo Fisher Scientific TMO$53.41B2025
Amgen AMGN$8.66B2025
Gilead Sciences GILD$22.70B2025
Abbott Laboratories ABT$52.13B2025
Novo Nordisk NVODKK 194.05B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on GILD

Gilead Sciences, figure by figure

Gilead Sciences (GILD) overview: price, valuation and scorecardAll health care companies by market value

Gilead Sciences net assets (shareholders' equity): questions and answers

What are Gilead Sciences's net assets?

Gilead Sciences (GILD) had net assets of $22.70B at the end of fiscal 2025 (December 31, 2025). That is 17.4% higher than the $19.33B of fiscal 2024.

What is the growth rate of Gilead Sciences's net assets?

Over the five fiscal years to 2025 net assets grew at a compound 4.5% a year; over ten years the rate was 2.0% a year.

What are the highest and lowest net assets figures on record for Gilead Sciences?

Across the 19 fiscal years on record (2007–2025), the highest was $22.83B in fiscal 2023 and the lowest $3.75B in fiscal 2007.

How is Gilead Sciences's net assets calculated?

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value. For Gilead Sciences it is on record here for 19 fiscal years, 2007 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Gilead Sciences (GILD) net assets (shareholders' equity)”, data as of 18 November 2026. https://funkfolio.com/stock/GILD/net-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.